HA60

Technical Properties

The HA60 Disposable Hemoperfusion Cartridge is a medical device specifically designed for pediatric patients with low body weight. It has the following technical properties:

• Adsorbent Volume: 60 ml
• Blood Volume: 65-20 ml
• Adsorbent Material: Double crosslinked styrene-divinylbenzene copolymers
• Housing Material: Polycarbonate
• Sterilization Method: Irradiation sterilization

The adsorbent volume of 60 ml allows for efficient removal of toxins and waste products from the patient’s blood during hemoperfusion. This ensures that the cartridge can effectively cleanse the blood while maintaining a compact size suitable for pediatric patients with low body weight.

The blood volume range of 65-20 ml indicates the capacity of the cartridge to accommodate varying blood volumes within the specified range. This flexibility allows for precise control and adaptation to the patient’s specific needs, ensuring optimal treatment outcomes.

The adsorbent material used in the HA60 Disposable Hemoperfusion Cartridge is double crosslinked styrene-divinylbenzene copolymers. This material possesses excellent adsorption properties, enabling it to effectively capture and remove a wide range of toxins and waste products from the patient’s bloodstream.

The housing material of the cartridge is made of polycarbonate, a durable and biocompatible material that ensures the integrity and safety of the device. Polycarbonate is known for its strength and resistance to impact, making it suitable for medical applications where reliability and durability are crucial.

The HA60 Disposable Hemoperfusion Cartridge undergoes irradiation sterilization, a method that effectively eliminates microorganisms and ensures the cartridge’s sterility. This sterilization method is widely used in the medical field due to its effectiveness and ability to penetrate various materials without compromising their properties.

Overall, the technical properties of the HA60 Disposable Hemoperfusion Cartridge are carefully designed to provide efficient and safe hemoperfusion therapy for pediatric patients with low body weight. The combination of the adsorbent volume, blood volume range, adsorbent material, housing material, and sterilization method ensures optimal performance and patient care.

Clinical Benefits

The HA60 Disposable Hemoperfusion Cartridge is used in extracorporeal blood purification therapy for pediatric patients. It offers several clinical benefits and is indicated for the following conditions:

Renal Failure

The HA60 cartridge can be used in the treatment of renal failure, a condition where the kidneys are unable to adequately filter waste products from the blood. By selectively adsorbing cytokines and inflammatory mediators, the cartridge helps reduce inflammation and improve overall kidney function.

Chronic Kidney Disease

Patients with chronic kidney disease often experience a buildup of toxins and waste products in their bloodstream. The HA60 cartridge can effectively remove these substances, helping to alleviate symptoms and slow down the progression of the disease.

Uremia and Complications Related to Hemodialysis

Uremia, a condition characterized by high levels of urea and other waste products in the blood, can occur in patients undergoing hemodialysis. The HA60 cartridge can aid in the removal of uremic toxins, reducing the risk of complications associated with hemodialysis.

The HA60 Disposable Hemoperfusion Cartridge is manufactured by Jafron, a trusted company in the medical device industry. It is specifically designed to selectively adsorb cytokines and other inflammatory mediators from the bloodstream in conditions where inflammation is a factor.

For example, in cases of sepsis, a life-threatening condition caused by a severe infection, the HA60 cartridge can help remove pro-inflammatory cytokines, contributing to the management of the patient’s condition. Similarly, in conditions like cytokine storm or severe acute pancreatitis, where excessive inflammation can lead to organ damage, the cartridge can provide targeted adsorption of inflammatory mediators, helping to mitigate the harmful effects of inflammation.

The HA60 cartridge contains polystyrene divinylbenzene resin beads that act as an adsorbent for the targeted molecules. These beads have a high affinity for cytokines and other inflammatory mediators, allowing for their efficient removal from the bloodstream during the hemoperfusion process.

In conclusion, the HA60 Disposable Hemoperfusion Cartridge is a valuable tool in extracorporeal blood purification therapy for pediatric patients. With its specific design and adsorbent properties, it offers clinical benefits in the treatment of renal failure, chronic kidney disease, uremia, and complications related to hemodialysis. Manufactured by Jafron, a reputable medical device company, the HA60 cartridge provides targeted adsorption of cytokines and inflammatory mediators, contributing to the management of conditions where inflammation plays a significant role.

In addition to its clinical benefits, the HA60 cartridge also offers practical advantages. Its disposable nature eliminates the need for complex cleaning and sterilization processes, reducing the risk of contamination and ensuring patient safety. The cartridge is designed to be user-friendly, with clear instructions and intuitive connections that make it easy to incorporate into existing extracorporeal blood purification systems. Furthermore, the HA60 cartridge is compatible with a wide range of blood pumps and dialysis machines, providing flexibility for healthcare providers and allowing for seamless integration into different treatment protocols.

Another advantage of the HA60 cartridge is its cost-effectiveness. By providing targeted adsorption of cytokines and inflammatory mediators, the cartridge helps reduce the need for additional medications and therapies, potentially lowering overall treatment costs. Additionally, the disposable nature of the cartridge eliminates the need for costly maintenance and replacement parts, further contributing to cost savings for healthcare facilities.

Overall, the HA60 Disposable Hemoperfusion Cartridge offers not only clinical benefits but also practical advantages in the field of extracorporeal blood purification therapy. Its ability to selectively adsorb cytokines and inflammatory mediators, combined with its user-friendly design and cost-effectiveness, makes it a valuable tool for healthcare providers seeking to improve patient outcomes in pediatric patients with renal failure, chronic kidney disease, uremia, and complications related to hemodialysis.